Global retinal nerve fibre layer thickness (RNFLT-G) 6 months [clinicaltrials_resource:08f824b21a233f1f1d2f3d23552b4243]
Determination of the efficacy of erythropoietin compared to placebo given as add-on to methylprednisolone (standard of care) as assessed by measurement of global retinal nerve fibre layer thickness (RNFLT-G) in the affected eye 6 months after randomisation.
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]
Global retinal nerve fibre layer thickness (RNFLT-G) 6 months [clinicaltrials_resource:08f824b21a233f1f1d2f3d23552b4243]
Determination of the efficacy of erythropoietin compared to placebo given as add-on to methylprednisolone (standard of care) as assessed by measurement of global retinal nerve fibre layer thickness (RNFLT-G) in the affected eye 6 months after randomisation.
Bio2RDF identifier
08f824b21a233f1f1d2f3d23552b4243
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:08f824b21a233f1f1d2f3d23552b4243
measure [clinicaltrials_vocabulary:measure]
Global retinal nerve fibre layer thickness (RNFLT-G)
time frame [clinicaltrials_vocabulary:time-frame]
description
Determination of the efficacy ...... 6 months after randomisation.
identifier
clinicaltrials_resource:08f824b21a233f1f1d2f3d23552b4243
title
Global retinal nerve fibre layer thickness (RNFLT-G) 6 months
@en
type
label
Global retinal nerve fibre lay ...... 824b21a233f1f1d2f3d23552b4243]
@en